The Patent Finder
US

Substituted 2,3-Dihydroimidazo[1,2-c]quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis

US 8,466,283 Surrendered on reissue
OverviewSources & methods

Surrendered on reissue May 22, 2018 · Low confidence

Surrendered on reissue May 22, 2018 · its term and maintenance fees continue in US RE46,856.

Held by Bayer Intellectual Property GmbH
Filed Dec 20, 2010 as application 12/517,875 · Granted Jun 18, 2013
Base term, 20 years from filing, plus 687 days of patent term adjustment (USPTO delay)
Today
Surrendered May 22, 2018
2007 2029
Clock starts
Dec 5, 2007
No longer in force
May 22, 2018
Granted
Jun 18, 2013
Term would have run to
Oct 22, 2029
base term patent term adjustment after the term ends fee events Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
687
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Fees paid on this patent before its reissue. Those after fall due on the reissue, which carries the term on.

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
Step Input Date after this step Confidence
Base term, 20 years from filingClock starts Dec 5, 2007, when the earliest non-provisional application in its chain was filed (this one was filed Dec 20, 2010)Dec 5, 2027High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+687 days, USPTO patent term adjustment recordOct 22, 2029High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee eventsNo fee event states this; the fee state is read from the payments the fee record holds; the fee record shows no payment for this window, and USPTO's status still reads "Patented Case"no changeLow confidence
ReissueUS RE46,856 issued May 22, 2018, and this patent's term continues in it (35 U.S.C. 251, 252)surrendered May 22, 2018High confidence
Surrendered on reissueThe steps above, in orderMay 22, 2018Low confidence

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.

Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited